ATIVAN Drug Patent Profile
✉ Email this page to a colleague
When do Ativan patents expire, and what generic alternatives are available?
Ativan is a drug marketed by Hikma and Bausch and is included in two NDAs.
The generic ingredient in ATIVAN is lorazepam. There are eleven drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the lorazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ativan
A generic version of ATIVAN was approved as lorazepam by SANDOZ on April 21st, 1987.
Summary for ATIVAN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 50 |
Clinical Trials: | 42 |
Patent Applications: | 4,490 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ATIVAN |
What excipients (inactive ingredients) are in ATIVAN? | ATIVAN excipients list |
DailyMed Link: | ATIVAN at DailyMed |
Recent Clinical Trials for ATIVAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Children's Hospital Los Angeles | Phase 2 |
University of Colorado, Denver | Phase 2 |
Jayasree Basivireddy | Phase 3 |
Pharmacology for ATIVAN
Drug Class | Benzodiazepine |
Anatomical Therapeutic Chemical (ATC) Classes for ATIVAN
US Patents and Regulatory Information for ATIVAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | ATIVAN | lorazepam | TABLET;ORAL | 017794-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | ATIVAN | lorazepam | TABLET;ORAL | 017794-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | ATIVAN | lorazepam | TABLET;ORAL | 017794-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ATIVAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-002 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ATIVAN
See the table below for patents covering ATIVAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 2302659 | ⤷ Try a Trial | |
France | 2181679 | ⤷ Try a Trial | |
South Africa | 7209004 | ⤷ Try a Trial | |
Australia | 5024072 | ⤷ Try a Trial | |
Belgium | 794224 | ⤷ Try a Trial | |
Netherlands | 7300694 | ⤷ Try a Trial | |
Ireland | 38298 | PARENTERAL BENZODIAZEPINE COMPOSITIONS | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |